29 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
and integration of business development transactions, and a deep understanding of the regulatory environment of the healthcare markets. Our management team also … candidates when studied in a controlled environment with a placebo or active control.
Interim, topline or preliminary data from our clinical studies
8-K
EX-99.1
fgoscrkc2i
13 Nov 23
AEON Biopharma Reports Third Quarter 2023 Financial Results
9:00am
8-K
EX-99.3
k7p8f ublp
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K
EX-99.2
8ahsch
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K
idhxhgbr
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K
EX-99.1
p8hp xu44qr
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K
EX-14.1
7ex8wwtwmnqe7
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-99.4
x1oftudn kn
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-99.1
92j2yrm08uvmm9db4xt
24 Jul 23
Corporate Presentation July 2023
6:43am